Tokyo Tape
Sign in
← Yamashita Health Care Holdings

Quarterly report · Q2

9265.TEDINET S100PWJZ
Period2022-06-01 → 2022-11-30
Filed2023-01-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥27.7bn2022-06-01 → 2022-11-30Cons.Net sales
Revenue¥55.1bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥27.3bn2021-06-01 → 2021-11-30Cons.Net sales
Operating income¥598m2022-06-01 → 2022-11-30Cons.Operating income
Operating income¥663m2021-06-01 → 2021-11-30Cons.Operating income
Ordinary income¥624m2022-06-01 → 2022-11-30Cons.Ordinary income
Ordinary income¥1.0bn2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥701m2021-06-01 → 2021-11-30Cons.Ordinary income
Profit before tax¥20m2022-06-01 → 2022-11-30Cons.Income before income taxes
Profit before tax¥713m2021-06-01 → 2021-11-30Cons.Income before income taxes
Net income (owners)−¥201m2022-06-01 → 2022-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥696m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥471m2021-06-01 → 2021-11-30Cons.Profit loss attributable to owners of parent
Net income−¥204m2022-06-01 → 2022-11-30Cons.Profit loss
Net income¥471m2021-06-01 → 2021-11-30Cons.Profit loss
Total assets¥22.9bnat 2022-11-30Cons.Assets
Total assets¥24.1bnat 2022-05-31Cons.Assets
Total assets¥25.1bnat 2021-11-30Cons.Total assets (5-year summary)
Total liabilities¥15.3bnat 2022-11-30Cons.Liabilities
Total liabilities¥16.1bnat 2022-05-31Cons.Liabilities
Net assets / equity¥7.6bnat 2022-11-30Cons.Net assets
Net assets / equity¥8.0bnat 2022-05-31Cons.Net assets
Net assets / equity¥7.9bnat 2021-11-30Cons.Net assets (5-year summary)
Cash and deposits¥1.8bnat 2022-11-30Cons.Cash and deposits
Cash and deposits¥4.0bnat 2022-05-31Cons.Cash and deposits
Cash & equivalents¥1.8bnat 2022-11-30Cons.Cash and cash equivalents
Cash & equivalents¥4.0bnat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥2.4bnat 2021-11-30Cons.Cash and cash equivalents
Cash & equivalents¥3.7bnat 2021-05-31dCons.Cash and cash equivalents
Operating cash flow−¥1.9bn2022-06-01 → 2022-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥581m2021-06-01 → 2022-05-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥751m2021-06-01 → 2021-11-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥88m2022-06-01 → 2022-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥27m2021-06-01 → 2022-05-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥318m2021-06-01 → 2021-11-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥209m2022-06-01 → 2022-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥229m2021-06-01 → 2022-05-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥229m2021-06-01 → 2021-11-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-78.982022-06-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-143.682022-09-01 → 2022-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥272.672021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥184.812021-06-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥128.292021-09-01 → 2021-11-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio33.2%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio33.1%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.3%at 2021-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-06-01 → 2022-11-30−¥11m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2022-11-30−¥11m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2022-11-30−¥447m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2022-06-01 → 2022-11-30¥140m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2022-06-01 → 2022-11-30¥140m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2022-06-01 → 2022-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2022-06-01 → 2022-11-30¥3m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue2022-06-01 → 2022-11-30¥27.5bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue external2022-06-01 → 2022-11-30¥27.5bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2022-06-01 → 2022-11-30¥11m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentsegment profit2022-06-01 → 2022-11-30¥1.0bn
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue2022-06-01 → 2022-11-30¥33m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue external2022-06-01 → 2022-11-30¥33m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentsegment profit2022-06-01 → 2022-11-30¥0
—segment totalrevenue2022-06-01 → 2022-11-30¥27.7bn
—segment totalrevenue external2022-06-01 → 2022-11-30¥27.7bn
—segment totalrevenue intersegment2022-06-01 → 2022-11-30¥11m
—segment totalsegment profit2022-06-01 → 2022-11-30¥1.0bn
Reconciling Itemsreconcilingrevenue2021-06-01 → 2021-11-30¥0
Reconciling Itemsreconcilingrevenue intersegment2021-06-01 → 2021-11-30¥0
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2021-11-30−¥415m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2021-06-01 → 2021-11-30¥136m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2021-06-01 → 2021-11-30¥136m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2021-06-01 → 2021-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2021-06-01 → 2021-11-30¥3m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue2021-06-01 → 2021-11-30¥27.2bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue external2021-06-01 → 2021-11-30¥27.2bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2021-06-01 → 2021-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentsegment profit2021-06-01 → 2021-11-30¥1.1bn
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue2021-06-01 → 2021-11-30¥34m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue external2021-06-01 → 2021-11-30¥34m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentsegment profit2021-06-01 → 2021-11-30¥0
—segment totalrevenue2021-06-01 → 2021-11-30¥27.3bn
—segment totalrevenue external2021-06-01 → 2021-11-30¥27.3bn
—segment totalrevenue intersegment2021-06-01 → 2021-11-30¥0
—segment totalsegment profit2021-06-01 → 2021-11-30¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 487
ItemContextValueUnit
Current liabilitiesPrior1YearInstant15555000000JPY
Current liabilitiesCurrentQuarterInstant14611000000JPY
Net defined benefit liabilityPrior1YearInstant237000000JPY
Net defined benefit liabilityCurrentQuarterInstant222000000JPY
Other nclPrior1YearInstant287000000JPY
Other nclCurrentQuarterInstant429000000JPY
Noncurrent liabilitiesPrior1YearInstant525000000JPY
Noncurrent liabilitiesCurrentQuarterInstant652000000JPY
LiabilitiesPrior1YearInstant16081000000JPY
LiabilitiesCurrentQuarterInstant15264000000JPY
Capital stockPrior1YearInstant494000000JPY
Capital stockCurrentQuarterInstant494000000JPY
Capital surplusPrior1YearInstant627000000JPY
Capital surplusCurrentQuarterInstant627000000JPY
Retained earningsPrior1YearInstant6296000000JPY
Retained earningsCurrentQuarterInstant5885000000JPY
Treasury stockPrior1YearInstant-0JPY
Treasury stockCurrentQuarterInstant-0JPY
Shareholders equityPrior1YearInstant7417000000JPY
Shareholders equityCurrentQuarterInstant7006000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant651000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant653000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-88000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-77000000JPY
Valuation and translation adjustmentsPrior1YearInstant562000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant575000000JPY
Non controlling interestsPrior1YearInstant24000000JPY
Non controlling interestsCurrentQuarterInstant21000000JPY
Net assetsPrior1YearInstant8005000000JPY
Net assetsCurrentQuarterInstant7604000000JPY
Liabilities and net assetsPrior1YearInstant24086000000JPY
Liabilities and net assetsCurrentQuarterInstant22869000000JPY
Net salesPrior1YTDDuration27335000000JPY
Net salesCurrentYTDDuration27661000000JPY
Cost of salesPrior1YTDDuration23667000000JPY
Cost of salesCurrentYTDDuration23920000000JPY
Gross profitPrior1YTDDuration3667000000JPY
Gross profitCurrentYTDDuration3741000000JPY
Selling general and administrative expensesPrior1YTDDuration3004000000JPY
Selling general and administrative expensesCurrentYTDDuration3143000000JPY
Operating incomePrior1YTDDuration663000000JPY
Operating incomeCurrentYTDDuration598000000JPY
Interest and dividends income noiPrior1YTDDuration5000000JPY
Interest and dividends income noiCurrentYTDDuration5000000JPY
Purchase discounts noiPrior1YTDDuration7000000JPY
Purchase discounts noiCurrentYTDDuration7000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration10000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration－JPY
Commission fee noiPrior1YTDDuration12000000JPY
Commission fee noiCurrentYTDDuration12000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-05-31pass
balance sheet identityconsolidated 2022-11-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2021-11-30pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2022-11-30pass
statement vs summary · operating cash flowconsolidated 2021-06-01/2021-11-30pass
statement vs summary · operating cash flowconsolidated 2022-06-01/2022-11-30pass
statement vs summary · revenueconsolidated 2021-06-01/2021-11-30pass
statement vs summary · revenueconsolidated 2022-06-01/2022-11-30pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2022-11-30pass